INDSWFTLAB - Ind-Swift Laboratories

Ind-Swift Laboratories

INDSWFTLAB · Pharma > Pharmaceuticals & Drugs · Chairman: N R Munjal · MD: N R Munjal · Listing date: July 17, 1997 · Employees: 1531 · Chandigarh · http://www.indswiftlabs.com

Stock Price vs Company Growth

4.1%

7.6%

11.0%

43.3%

31.9%

53.0%

12.3%

10y

10.8%

all

5.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 131 4.1%

87.5

152

Company Overview

Sales

594 Cr

Growth: -20.9%

Profit after Tax

32.7 Cr

Growth: 85.1%

Small Cap

1,136 Cr

P/E: 4.0x

Industry P/E: 27.1x

Fundamentals

Sales (Cr)	₹ 594
Growth	-20.9%
EBITDA	0.0%
P/S	1.9x
Dividend	0.0%
P/E	4.0x
Book Value	₹ 148
PEG Ratio	-0.2x
ROE	2.6%
P/B	0.9x

Shareholding Pattern

Institutions

Edelweiss India Special Situations Fund Ii

10.43 %

Ec Special Situations Fund

6.82 %

Ashokkumar Chandak

2.79 %

Eisaf Ii Onshore Fund

2.24 %

Sri Ganesh Biotech Private Limited

1.26 %

Promoters

Essix Biosciences Limited

21.71 %

Ind Swift Ltd

16.08 %

N.R. Munjal

1.56 %

Rishav Mehta

0.77 %

Himanshu Jain

0.69 %

Others

Increase Decrease No change

Company Profile Detailed

Ind-Swift Laboratories is a part of the Ind-swift Group and is based at Chandigarh, India. It has been promoted by Ind-Swift Limited in a joint venture with the Punjab State Industrial Development Corporation Limited (PSIDC). The group has established a strong reputation as innovators in the Indian pharmaceutical industry. Ind-Swift Laboratories Ltd. went public in 1997 and concentrated on the manufacturing of Active Pharmaceutical Ingredients (API).

Investors (116)

v.r.meht...

gopal.mu...

eisaf.ii...

Followers (1)

murali5